Quantcast
Indonesia approves J&J, Cansino COVID-19 vaccines for emergency use – Metro US

Indonesia approves J&J, Cansino COVID-19 vaccines for emergency use

Employee works on the production line of CanSino’s single-dose COVID-19
Employee works on the production line of CanSino’s single-dose COVID-19 vaccine in Tianjin

JAKARTA (Reuters) – Indonesia has approved the single-dose COVID-19 vaccines produced by Janssen Pharmaceutical Companies, part of Johnson & Johnson, and China’s CanSino Biological Inc for emergency use, the country’s food and drug agency said in a statement on Tuesday.

(Reporting by Stanley Widianto; Writing by Gayatri Suroyo; Editing by Ed Davies)